ok, i'll bite.
How exactly are "receptor occupancy concerns addressed, underway, and will be resolved?"
Receptor occupancy concerns have been underway for at least eight months.
What is different about receptor occupancy in the next three months that is different than the previous eight months?
Lets suppose that some lab somewhere is working for CYDY on a CCR5 receptor occupancy test. Lets further suppose its just terrific when its finished.
(Of course that begs the question of what took so long, but why nit-pick?)
So a month from now CYDY will have the perfect receptor occupancy test.
Well then, what blood will this new receptor occupancy test be working on?
Is an existing HIV trial going to dose more patients?
Will a new HIV trial be initiated to provide some material for the new RO test?
Will existing stored and saved blood samples be offered for the new RO test?
That seems to me the primary question. If indeed a new RO test does become available, whose blood will be tested?
At the risk of nit-picking even further, why is an RO test even needed? What disposition does the RO provide?
I sent these questions in for the Monday call but nothing there. I will ask again to TEAM_CYDY@cytodyn.com but not expecting a response.
Another nit-pick I have is how can a lab result be discussed for over six months as a gating function for a BLA without describing the lab result that is needed to be achieved? Is it 95% RO after 4 weeks some sort of bar that must be passed?
If I am simply the last to know, please someone take pity on me
How exactly are "receptor occupancy concerns addressed, underway, and will be resolved?"
Receptor occupancy concerns have been underway for at least eight months.
What is different about receptor occupancy in the next three months that is different than the previous eight months?
Lets suppose that some lab somewhere is working for CYDY on a CCR5 receptor occupancy test. Lets further suppose its just terrific when its finished.
(Of course that begs the question of what took so long, but why nit-pick?)
So a month from now CYDY will have the perfect receptor occupancy test.
Well then, what blood will this new receptor occupancy test be working on?
Is an existing HIV trial going to dose more patients?
Will a new HIV trial be initiated to provide some material for the new RO test?
Will existing stored and saved blood samples be offered for the new RO test?
That seems to me the primary question. If indeed a new RO test does become available, whose blood will be tested?
At the risk of nit-picking even further, why is an RO test even needed? What disposition does the RO provide?
I sent these questions in for the Monday call but nothing there. I will ask again to TEAM_CYDY@cytodyn.com but not expecting a response.
Another nit-pick I have is how can a lab result be discussed for over six months as a gating function for a BLA without describing the lab result that is needed to be achieved? Is it 95% RO after 4 weeks some sort of bar that must be passed?
If I am simply the last to know, please someone take pity on me
4
